Idarucizumab
Product Specifications
CAS Number
1362509-93-0
Target
Thrombin
Related Pathways
Proteases/Proteasome
Bioactivity
Idarucizumab, a humanized monoclonal antibody fragment, serves as the first reversal agent for direct oral anticoagulants (DOACs) . It specifically neutralizes the effects of oral direct thrombin inhibitors, thereby restoring hemostasis [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
4090650/A 1 Each
Section Through The Stem Of A Year Old Dicotyle Plant
Sign In for Pricing
View Details 
039367-ML405 100 µL
OR2T11, CT (OR2T11, Olfactory receptor 2T11, Olfactory receptor OR1-65) (MaxLight 405) discontinued
Sign In for Pricing
View Details 